Overall rank by patents
#34,161
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Apirx Pharmaceutical USA, Llc
USPTO PatentsView assignee record - 7 granted patents across 7 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
7
Total patents granted
7
CPC technology areas
13.3
Avg claims per patent
-
5-year filing velocity
The verdict
Apirx holds 7 US patents across 7 technology areas, rank #34,161 of 50,000 tracked assignees.
- #34,161
- of 50,000 US assignees by volume
- Top 75%
- by Innovation Score (27.8/100)
- 13.3
- avg claims per patent
Portfolio overview
Apirx Pharmaceutical USA, Llc has been granted 7 US utility patents between 2020 and 2025, placing Apirx Pharmaceutical USA, Llc at rank #34,161 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.3 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Apirx Pharmaceutical USA, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Apirx sits between Aobiome Llc (7 patents, rank #34,157) and Applica SP. Z O.o. (7 patents, rank #34,165) - the closest US assignees by grant volume. The composite Innovation Score of 27.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 7 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Apirx Pharmaceutical USA, Llc's 13.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Apirx Pharmaceutical USA, Llc against peers pursuing similar technology classes.
Who files at Apirx's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Aobiome
AOBIOME LLC
7 patents
- AOP Orphan Pharma…
AOP Orphan Pharmaceuticals AG
7 patents
- APB
APB CORPORATION
7 patents
- Aperture Medical…
APERTURE MEDICAL TECHNOLOGY LLC
7 patents
- APL Technology AS
APL TECHNOLOGY AS
7 patents
- Apollo Precision…
APOLLO PRECISION KUNMING YUANHONG LIMITED
7 patents
- APOS—Medical and…
APOS—Medical and Sports Technologies Ltd.
7 patents
- Applica SP Z O O
APPLICA SP. Z O.O.
7 patents
- Apirx Pharmaceuti… ◀
APIRx Pharmaceutical USA, LLC
7 patents
What this shows Apirx holds 7 patents at rank #34,161, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Apirx
By rank, the assignees closest to #34,161 in granted patent volume.
- Aobiome Llc #34,157 · 7 patents
- AOP Orphan Pharmaceuticals Ag #34,158 · 7 patents
- APB Corporation #34,159 · 7 patents
- Aperture Medical Technology Llc #34,160 · 7 patents
- APL Technology AS #34,162 · 7 patents
- Apollo Precision Kunming Yuanhong Limited #34,163 · 7 patents
- Apos—medical And Sports Technologies Ltd. #34,164 · 7 patents
- Applica SP. Z O.o. #34,165 · 7 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Apirx's primary technology class.
- The Regents Of The University Of California 1,779 in class
- L'oreal 1,250 in class
- Novartis Ag 988 in class
- The Procter & Gamble Company 985 in class
- The Board Of Regents Of The University Of Texas System 950 in class
- The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 813 in class
- The Trustees Of The University Of Pennsylvania 768 in class
- Merck Sharp & Dohme Llc 760 in class
Apirx's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
28 Top 75% higher than 25% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 14.3% |
| 2021 | 3 | 42.9% |
| 2022 | 1 | 14.3% |
| 2024 | 1 | 14.3% |
| 2025 | 1 | 14.3% |
Which technologies does Apirx Pharmaceutical USA, Llc patent most?
Top 7 of 7 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Frequently Asked Questions
How many patents does Apirx Pharmaceutical USA, Llc hold?
Apirx Pharmaceutical USA, Llc holds 7 US granted patents filed between 2020 and 2025, spanning 7 technology areas.
What is Apirx Pharmaceutical USA, Llc's Innovation Score?
Apirx Pharmaceutical USA, Llc has an Innovation Score of 27.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Apirx Pharmaceutical USA, Llc focus on?
Apirx Pharmaceutical USA, Llc's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 6 patents. The company has filed patents in 7 CPC subclasses total.
Is Apirx Pharmaceutical USA, Llc's patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Apirx Pharmaceutical USA, Llc.
What does claim depth mean for Apirx Pharmaceutical USA, Llc's patents?
Apirx Pharmaceutical USA, Llc's patents average 13.3 claims each. This falls within the standard range, providing solid legal coverage.
How is the Apirx Pharmaceutical USA, Llc patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Apirx's 7 grants land it in the top 75% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Apirx ranks #34,161 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.